Zura Bio Ltd (NASDAQ:ZURA)’s traded shares stood at 0.81 million during the last session, with the company’s beta value hitting -0.02. At the close of trading, the stock’s price was $2.88, to imply an increase of 2.86% or $0.08 in intraday trading. The ZURA share’s 52-week high remains $6.35, putting it -120.49% down since that peak but still an impressive 30.56% since price per share fell to its 52-week low of $2.00. The company has a valuation of $188.04M, with an average of 0.38 million shares in intraday trading volume over the past 10 days and average of 457.62K shares over the past 3 months.
Analysts have given a consensus recommendation of Buy for Zura Bio Ltd (ZURA), translating to a mean rating of 1.22. Of 11 analyst(s) looking at the stock, 0 analyst(s) give ZURA a Sell rating. 1 of those analysts rate the stock as Overweight while 2 advise Hold as 8 recommend it as a Buy. 0 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at 0.
Zura Bio Ltd (NASDAQ:ZURA) trade information
After registering a 2.86% upside in the last session, Zura Bio Ltd (ZURA) has traded red over the past five days. The 5-day price performance for the stock is -5.57%, and -33.02% over 30 days. With these gigs, the year-to-date price performance is -38.33%. Short interest in Zura Bio Ltd (NASDAQ:ZURA) saw shorts transact 4.96 million shares and set a 13.53 days time to cover.
The extremes give us $5 and $15 for target low and target high price respectively. As such, ZURA has been trading -420.83% off suggested target high and -73.61% from its likely low.
Zura Bio Ltd (ZURA) estimates and forecasts
Looking at statistics comparing Zura Bio Ltd share performance against respective industry, we note that the company has outperformed competitors. Zura Bio Ltd (ZURA) shares are -28.18% down over the last 6 months, with its year-to-date growth rate higher than industry average at 68.90% against 17.50%.
ZURA Dividends
Zura Bio Ltd has its next earnings report out in January. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
Zura Bio Ltd (NASDAQ:ZURA)’s Major holders
Zura Bio Ltd insiders hold 31.87% of total outstanding shares, with institutional holders owning 58.02% of the shares at 85.16% float percentage. In total, 58.02% institutions holds shares in the company.
